Assessment the role of tranexamic acid in prevention of postpartum hemorrhage

Ain-Shams Journal of Anesthesiology - Tập 13 Số 1 - 2021
Nevein Gerges Fahmy1, Fahmy Saad Latif Eskandar1, Walid Albasuony Mohammed Ahmed Khalil2, Mohammed Ibrahim Ibrahim Sobhy1, Amin Mohammed Al Ansary Amin1
1Department of Anesthesiology, Intensive care and Pain Management, Faculty of Medicine, Ain-Shams University, Abbassia, Cairo, 11591, Egypt
2Department of Obstetrics and Gynecology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Tóm tắt

Abstract Background Postpartum hemorrhage (PPH) is one of the leading causes of maternal mortality and morbidity worldwide. It is believed that hemostatic imbalance secondary to release of tissue plasminogen activator (tPA) and subsequent hyperfibrinolysis plays a major role in PPH pathogenesis. Antifibrinolytic drugs such as tranexamic acid (TXA) are widely used in hemorrhagic conditions associated with hyperfibrinolysis. TXA reduced maternal death due to PPH and its use as a part of PPH treatment is recommended, and in recent years, a number of trials have investigated the efficacy of prophylactic use of TXA in reducing the incidence and the severity of PPH. The study is aiming to assess the efficacy of tranexamic acid in reducing blood loss throughout and after the lower segment cesarean section and reducing the risk of postpartum hemorrhage. Results The amount of blood loss was significantly lower in the study group than the control group (416.12±89.95 and 688.68±134.77 respectively). Also the 24-h postoperative hemoglobin was significantly higher in the study group (11.66±0.79 mg/dl) compared to the control group (10.53±1.07mg/dl), and the 24-h postoperative hematocrit value was significantly higher in the study group (34.99±2.40) compared to control (31.62±3.22). Conclusion Prophylactic administration of tranexamic acid reduces intraoperative and postoperative bleeding in cesarean section and the incidence of postpartum hemorrhage.

Từ khóa


Tài liệu tham khảo

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM (2013) Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. J Matern Neonatal Med 26(17):1705–1709 [cited 2021 Jan 10]

Alam A, Bopardikar A, Au S, Barrett J, Callum J, Kiss A et al (2017) Protocol for a pilot, randomised, double-blinded, placebo-controlled trial of prophylactic use of tranexamic acid for preventing postpartum haemorrhage (TAPPH-1). BMJ Open 7(10):1–8

Butterworth J, Mackey DC, Wasnick J (2013) Chapter 51. Fluid Management & Blood Component Therapy. In: Morgan & Mikhail’s clinical anesthesiology, 5e | AccessMedicine McGraw-Hill Medical [Internet]. [cited 2021 Jan 10]. McGraw-Hill, New York, p 1168

Committee on Practice Bulletins-Obstetrics (2017) Practice bulletin no. 183: postpartum hemorrhage. Obstet Gynecol 130(4):e168–e186. https://doi.org/10.1097/AOG.0000000000002351

Ducloy-Bouthors A-S, Jeanpierre E, Saidi I, Baptiste A-S, Simon E, Lannoy D et al (2018) TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial. Trials 19(1):1–16.

Kandappan G, Anand B (2016) Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section in multigravida parturients: a case controlled prospective study. J Evid Based Med Healthc 3(48):2419–2425. https://doi.org/10.18410/jebmh/2016/532

Lier H, Maegele M, Shander A (2019) Tranexamic acid for acute hemorrhage: a narrative review of landmark studies and a critical reappraisal of its use over the last decade. Anesth Analg 129(6):1574–1584. https://doi.org/10.1213/ANE.0000000000004389

Neb H, Zacharowski K, Meybohm P (2017) Strategies to reduce blood product utilization in obstetric practice. Curr Opin Anaesthesiol 30(3):294–299. https://doi.org/10.1097/ACO.0000000000000463

Pabinger I, Fries D, Schöchl H, Streif W, Toller W (2017) Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr 129(9–10):303–316. https://doi.org/10.1007/s00508-017-1194-y

Pacheco LD, Hankins GDV, Saad AF, Costantine MM, Chiossi G, Saade GR (2017) Tranexamic acid for the management of obstetric hemorrhage. Obstet Gynecol 130(4):765–769. https://doi.org/10.1097/AOG.0000000000002253

Pacheco LD, Saade GR, Hankins GDV (2019) Medical management of postpartum hemorrhage: an update. Semin Perinatol 43(1):22–26. https://doi.org/10.1053/j.semperi.2018.11.005

Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, Cook L, Kawahara T, Perel P, Prieto-Merino D, Ramos M, Cairns J, Guerriero C (2013) The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess 17(10):1–79. https://doi.org/10.3310/hta17100

Salem M, Mohamed M, Salem A, Abbas A (2016) Tranexamic acid as prophylactic therapy for intra and post partum hemorrhage, randomized controlled trial. Br J Med Med Res 17(2):1–7. https://doi.org/10.9734/BJMMR/2016/26288

Sentilhes L, Daniel V, Deneux-Tharaux C (2020) TRAAP2-TRAnexamic acid for preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo-controlled trial- a study protocol. BMC Pregnancy Childbirth 20(1):1–11

Sentürk MB, Cakmak Y, Yildiz G, Yildiz P (2013) Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial. Arch Gynecol Obstet 287(4):641–645. https://doi.org/10.1007/s00404-012-2624-8

Shakur H, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, Akintan A et al (2017) Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 389(10084):2105–2116. https://doi.org/10.1016/S0140-6736(17)30638-4

Solomon C, Collis RE, Collins PW (2012) Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth 109(6):851–863. https://doi.org/10.1093/bja/aes361

Xu J, Gao W, Ju Y (2013) Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch Gynecol Obstet 287(3):463–468. https://doi.org/10.1007/s00404-012-2593-y

Thông tin
Thông tin xuất bản

Ain-Shams Journal of Anesthesiology

Tập 13 Số 1

Thông tin tác giả